help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rothe, L.
Right arrow Articles by Osdoby, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rothe, L.
Right arrow Articles by Osdoby, P.
Endocrinology Vol. 139, No. 10 4353-4363
Copyright © 1998 by The Endocrine Society


ARTICLES

Human Osteoclasts and Osteoclast-Like Cells Synthesize and Release High Basal and Inflammatory Stimulated Levels of the Potent Chemokine Interleukin-81

Linda Rothe, Patricia Collin-Osdoby, Yan Chen, Teresa Sunyer, Lala Chaudhary, Alfie Tsay, Steven Goldring, Louis Avioli and Philip Osdoby

Department of Biology (L.R., P.C.-O., Y.C., T.S., P.O.) and Division of Bone and Mineral Research (P.C.-O., Y.C., L.C., L.A., P.O.), Washington University, St. Louis, Missouri 63130; and the Department of Rheumatology (A.T., S.G.), Harvard Institutes of Medicine, Boston, Massachusetts 02115

Address all correspondence and requests for reprints to: Dr. Philip Osdoby, Department of Biology, Box 1229, Washington University, St. Louis, Missouri 63130. E-mail: osdoby{at}biodec.wustl.edu

Chemokines, including interleukin-8 (IL-8), function as key mediators in diverse inflammatory disorders via promoting the recruitment, proliferation, and activation of vascular and immune cells. IL-8 levels are elevated in inflammatory diseases, such as rheumatoid arthritis, osteoarthritis, osteomyelitis, and periodontal disease, that also exhibit progressive bone loss. Therefore, it is possible that IL-8 contributes to the osteopenia associated with these pathological conditions. Although macrophages, neutrophils, and endothelial cells are considered the primary sources of inflammation-induced IL-8 increases, we report here for the first time that human bone marrow-derived osteoclast-like cells (hOCL) as well as authentic bone-resorbing human osteoclasts (hOC) isolated from osteoporotic femoral heads express messenger RNA (mRNA) for IL-8 and secrete high levels of IL-8 during culture. Basal IL-8 release by cultured hOC or hOCL was orders of magnitude greater than the release of the proinflammatory cytokines IL-1ß, IL-6, and tumor necrosis factor-{alpha}. At a cellular level, in situ hybridization analysis revealed that IL-8 mRNA was expressed in resorbing hOC of rheumatoid arthritic pannus and was substantially greater than that expressed in hOC of noninflammatory giant cell tumor of bone tissue. Therefore, the potential inflammation-mediated induction of IL-8 was directly assessed using cultured hOCL. IL-8 release was stimulated by proinflammatory signals (IL-1{alpha}, tumor necrosis factor-{alpha}, lipopolysaccharide, or phorbol 12-myristate 13-acetate), unaffected by various other osteotropic modulators (transforming growth factor-ß1 and -ß3, IL-6, 17ß-estradiol, or calcitonin) and was decreased by interferon-{gamma}, vitamin D3, and the antiinflammatory glucocorticoid dexamethasone. Changes in IL-8 secretion were paralleled by corresponding changes in IL-8 mRNA steady state levels. We conclude that hOC and hOCL synthesize and secrete high constitutive and inflammation-stimulated levels of the chemokine IL-8. Consequently, hOC-derived IL-8 could act as an important regulatory signal for bone, vascular, and immune cell recruitment and activation during normal and pathological bone remodeling.




This article has been cited by other articles:


Home page
EndocrinologyHome page
D. Onan, E. H. Allan, J. M. W. Quinn, J. H. Gooi, S. Pompolo, N. A. Sims, M. T. Gillespie, and T. J. Martin
The Chemokine Cxcl1 Is a Novel Target Gene of Parathyroid Hormone (PTH)/PTH-Related Protein in Committed Osteoblasts
Endocrinology, May 1, 2009; 150(5): 2244 - 2253.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Lorenzo, M. Horowitz, and Y. Choi
Osteoimmunology: Interactions of the Bone and Immune System
Endocr. Rev., June 1, 2008; 29(4): 403 - 440.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Yoneda, N. Ishimaru, R. Arakaki, M. Kobayashi, T. Izawa, K. Moriyama, and Y. Hayashi
Estrogen Deficiency Accelerates Murine Autoimmune Arthritis Associated with Receptor Activator of Nuclear Factor-{kappa}B Ligand-Mediated Osteoclastogenesis
Endocrinology, May 1, 2004; 145(5): 2384 - 2391.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
A S Taha, V Grant, and R W Kelly
Urinalysis for interleukin-8 in the non-invasive diagnosis of acute and chronic inflammatory diseases
Postgrad. Med. J., March 1, 2003; 79(929): 159 - 163.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
M. H. Cottler-Fox, T. Lapidot, I. Petit, O. Kollet, J. F. DiPersio, D. Link, and S. Devine
Stem Cell Mobilization
Hematology, January 1, 2003; 2003(1): 419 - 437.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Gurlek, M. R. Pittelkow, and R. Kumar
Modulation of Growth Factor/Cytokine Synthesis and Signaling by 1{alpha},25-Dihydroxyvitamin D3: Implications in Cell Growth and Differentiation
Endocr. Rev., December 1, 2002; 23(6): 763 - 786.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. S. Bendre, D. Gaddy-Kurten, T. Mon-Foote, N. S. Akel, R. A. Skinner, R. W. Nicholas, and L. J. Suva
Expression of Interleukin 8 and not Parathyroid Hormone-related Protein by Human Breast Cancer Cells Correlates with Bone Metastasis in Vivo
Cancer Res., October 1, 2002; 62(19): 5571 - 5579.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
U. N. Das
Nitric Oxide as the Mediator of the Antiosteoporotic Actions of Estrogen, Statins, and Essential Fatty Acids
Experimental Biology and Medicine, February 1, 2002; 227(2): 88 - 93.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Masood, S. Nagpal, T. Zheng, J. Cai, A. Tulpule, D. L. Smith, and P. S. Gill
Kaposi sarcoma is a therapeutic target for vitamin D3 receptor agonist
Blood, November 1, 2000; 96(9): 3188 - 3194.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
G. Schierano, F. Bassi, G. Gassino, K. Mareschi, G. Bellone, and G. Preti
Cytokine Production and Bone Remodeling in Patients wearing Overdentures on Oral Implants
Journal of Dental Research, September 1, 2000; 79(9): 1675 - 1682.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
P. Collin-Osdoby, L. Rothe, F. Anderson, M. Nelson, W. Maloney, and P. Osdoby
Receptor Activator of NF-kappa B and Osteoprotegerin Expression by Human Microvascular Endothelial Cells, Regulation by Inflammatory Cytokines, and Role in Human Osteoclastogenesis
J. Biol. Chem., June 1, 2001; 276(23): 20659 - 20672.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society